Particulate carrier systems as adjuvants for cancer vaccines-Reference-Cited by-同舟云学术

Particulate carrier systems as adjuvants for cancer vaccines

Published:2019 Issue:12 Volume:7 Page:4873-4887
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Saung May Tun¹²³⁴⁵,Ke Xiyu⁶⁷³⁴⁸,Howard Gregory P.⁶⁷³⁴⁹,Zheng Lei¹²³⁴⁵,Mao Hai-Quan⁶⁷³⁴⁸^ORCID

Affiliation:

1. Department of Oncology

2. Johns Hopkins University School of Medicine

3. Baltimore

4. USA

5. The Sidney Kimmel Cancer Center

6. Institute for NanoBioTechnology

7. Johns Hopkins University

8. Department of Materials Science and Engineering

9. Department of Biomedical Engineering

Abstract

Particulate systems including nanoparticles and microparticles show great potential as carriers for antigen and adjuvant delivery in cancer vaccine development.

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2019/BM/C9BM00871C

Reference134 articles.

1. Cancer immunotherapy: moving beyond current vaccines

2. The Formation of Immunogenic Major Histocompatibility Complex Class II–Peptide Ligands in Lysosomal Compartments of Dendritic Cells Is Regulated by Inflammatory Stimuli

3. Developmental regulation of MHC class II transport in mouse dendritic cells

4. Toll-dependent selection of microbial antigens for presentation by dendritic cells

5. Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Trends on Nanovaccine Administration and Functionalization Strategies for Immunization;Journal of Computational Biophysics and Chemistry;2024-04-05

2. Tumor-derived autophagosome vaccines combined with immune adjuvants mediate antitumor immune responses via the neoantigen pathway;Neoplasma;2024

3. Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer;Pharmaceuticals;2023-09-29

4. Vaccination of TLR7/8 Agonist‐Conjugated Antigen Nanoparticles for Cancer Immunotherapy;Advanced Healthcare Materials;2023-04-25

5. Recent advances in respiratory immunization: A focus on COVID-19 vaccines;Journal of Controlled Release;2023-03